Blood pressure-the better biomarker: delay in clinical application.

Blood pressure-the better biomarker: delay in clinical application. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Blood pressure-the better biomarker: delay in clinical application. Abstract Text:

Thomas D Giles,Thomas D Giles,

"The truly great advances in our understanding of nature originated in a way almost diametrically opposed to induction. The intuitive grasp of the essentials of a large complex of facts leads the scientist to the postulation of a hypothetical law or laws. From these laws, he derives his conclusion."-Albert Einstein, "Induction and Deduction in Physics," Berliner Tageblatt, December 25, 1919, CPAE 7:28.

Blood pressure-the better biomarker: delay in clinical application. Publishing Authors By Initials

TD Giles,TD Giles,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Blood pressure-the better biomarker: delay in clinical application. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of clinical hypertension (Greenwich, Conn.

VOLUME: 9

Page Numbers: 918-20

Journal Abbreviation:

ISSN: 1524-6175

DAY: 29

MONTH: Dec

YEAR: 2007

Blood pressure-the better biomarker: delay in clinical application. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100888554

Blood pressure-the better biomarker: delay in clinical application. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Blood pressure-the better biomarker: delay in clinical application. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Blood pressure-the better biomarker: delay in clinical application.

AFFILIATION: From Tulane University School of Medicine, New Orleans, LA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Clin Hypertens (Greenwich)

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Blood pressure-the better biomarker: delay in clinical application Related Publications

• A perspective on telmisartan and cardiovascular risk.
• Adverse childhood experiences and childhood autobiographical memory disturbance.
• Adverse childhood experiences and prescribed psychotropic medications in adults.
• Allele-specific regulation of primary cilia function by the von Hippel-Lindau tumor suppressor.
• Assessing adaptive behaviour in the post-acute setting following traumatic brain injury: initial reliability and validity of the Adaptive Behaviour and Community Competency Scale (ABCCS).
• Bayesian inference for stochastic epidemic models with time-inhomogeneous removal rates.
• Blood pressure-the better biomarker: delay in clinical application.
• Brain stem gliomas: Patterns of Care in Victoria from 1998-2000.
• Cloretazine for the treatment of acute myeloid leukemia.
• Computational capabilities of recurrent NARX neural networks.
• Expression and regulation of anti-mullerian hormone in an oviparous species, the hen.
• Financial implications of plans to combat methicillin-resistant Staphylococcus aureus (MRSA) in an orthopaedic department.
• Hormone therapy and breast cancer: what factors modify the association?
• Institution of universal screening for Group B streptococcus (GBS) from a risk management protocol results in reduction of early-onset GBS disease in a tertiary obstetric unit.
• Is cancer risk associated with anger control and negative affect? Findings from a prospective cohort study.
• Learning long-term dependencies in NARX recurrent neural networks.
• Nelarabine activity in acute biphenotypic leukemia.
• Nicotine in blood in relation to smoking.
• Occupational exposure to ionizing and non-ionizing radiation and risk of glioma.
• On the distribution of performance from multiple neural-network trials.
• Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies.
• RECENT CASES OF DENTAL MALPRACTICE.
• Recurrent ectopic pregnancy.
• The cardiometabolic syndrome and calcium channel blocker combination drugs.
• The enduring effects of abuse and related adverse experiences in childhood : A convergence of evidence from neurobiology and epidemiology.
• The management of primary cutaneous melanoma in Victoria in 1996 and 2000.
• The oxygen effect on radiation-induced chromosome aberrations: breakage-versus-recombination hypotheses.
• The rs743572 common variant in the promoter of CYP17A1 is not associated with prostate cancer risk or circulating hormonal levels.
• The von Hippel-Lindau tumour suppressor interacts with microtubules through kinesin-2.
• Treatment of acute lymphoblastic leukaemia : a new era.